By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion ...

The German mRNA firm BioNTech has announced that it will buy local rival CureVac in an all-stock transaction that values ...

The Biontech logo can be seen on one of the company's warehouse buildings in Mainz. Sebastian Gollnow/dpa German drugmaker BioNTech reported Monday wider net loss in its first quarter with weak ...

The Biontech logo can be seen on one of the company's warehouse buildings in Mainz. The German pharmaceutical company BioNTech reported a substantial loss in the second quarter as it continues to ...

By Ugur Sahin and Özlem Türeci Dr. Sahin and Dr. Türeci are the scientific founders of BioNTech. This personal reflection is part of a series called Turning Points, in which writers explore ...